Institute of Genomics and Integrative Biology

CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) is a scientific research institute devoted primarily to biological research. It is a part of Council of Scientific and Industrial Research (CSIR), India.[1]

CSIR Institute of Genomics and Integrative Biology
AbbreviationCSIR-IGIB
MottoGenomics Knowledge Partner
Established1977
TypeGovernment organization
PurposeTo translate concepts developed in basic biological research to commercially viable technologies for health care
Location
  • Sukhdev Vihar, Mathura Road,
    Delhi-110 025.
Director
Anurag Agrawal
Parent organization
Council of Scientific and Industrial Research
Websitewww.igib.res.in
CSIR-IGIB South Campus

The institute was founded in 1977 as the Center for Biochemical Technology with a primary focus on biochemical research, but has since shifted its research focus to integrative biology.

Location

The Institute has two campuses in Delhi. The North Campus is the older of the two campuses and is in the campus of Delhi University, on Mall Road opposite to Jubilee Hall. The new campus is in South Delhi, on Mathura Road at Sukhdev Vihar.

History

IGIB was established in 1977 as the Center for Biochemical Technology (CBT). The Functional Genomics Unit was established in 1998 with the focus shifting from chemical to genomics research. The institute was renamed "Institute of Genomics and Integrative Biology" in 2002.

Achievements

In 2009, a team at the institute sequenced the genome of the wild-type zebrafish, with about 1.7 billion base pairs. This made the fish, which is native to the Himalayan region, the first vertebrate to have its whole genome sequenced in India, as previously Indian scientists had only sequenced bacteria and plant genomes.[2][3]

In December 2009, scientists at IGIB performed the first re-sequencing of a human genome in India.[4][5][6] The Institute also collaborated on decoding the first Sri Lankan [7][8] genome and Malaysian genome.[9] The Institute is also a member of the Open Personal Genomics Consortium.[10] Researchers at the institute also reported the first high-throughput next-generation sequencing based approach for detection and genetic epidemiology of SARS-CoV-2[11]

Genomics of rare genetic diseases

The institute has initiated a unique programme to use cutting-edge genomic technologies to understand Rare genetic diseases in India and pioneering the application of genomics for Precision Medicine in clinics. One of the programmes which has been initiated on this front is Genomics for Understanding Rare Disease, India Alliance Network (GUaRDIAN).[12] GUaRDIAN is a large-scale collaborative network of clinicians from around India trying to use genomics in clinical practice, with the focused aim to understand genetic structure of rare genetic diseases in India.[13]

The consortium aims at using cutting-edge genomics technology to enable identification of genetic variations in diseases and enable clinicians arrive at precise diagnosis for rare genetic disease. Apart from working closely with clinicians, the consortium aims to foster education, awareness and the widespread adoption of genomic technology in clinical settings, in addition to creating and disseminating the highest standards of genomic data generation and interpretation in India.[14]

In the few years, it has been able to work closely with clinicians in the network to be able to offer proof of principles for the application of Genomics for Precision Medicine.[15][16][17] A comprehensive programme for patient referral is also functional.[18]

IndiGen Programme for Public Health

The IndiGen programme on Public Health Genomics[19] aims to undertake whole genome sequencing  of 1000 Indian individuals representing diverse ethnic groups from India. The data generated as part of IndiGen would provide the baseline for allele frequencies of genetic variants for genetic epidemiology and aid policy decisions. The frequencies of clinically relevant genetic variants would form the template for enabling diagnostic approaches for prevalent genetic diseases and also for optimising therapies through pharmacogenomics.

Extension Centers (Branches)

The main IGIB campus is located at Mall Road, New Delhi near Delhi University North Campus. IGIB's alliance with the Biotech/Pharmaceuticals has led to its growth and setting up of two extension centers - one at South Delhi (IGIB Annex at TCGA, Okhla) and the other at Western Delhi at Naraina.

International Meetings

IGIB was a co-host of the 13th meeting of the Human Genome Organization (HUGO) in 2008, held at Hyderabad International Convention Centre.[20]

gollark: Er, pretty sure he said 2 CBs.
gollark: Maybe someone offered a hatchling.
gollark: Strange.
gollark: Ah, greens are rarer.
gollark: Definitely more than two.

See also

References
  1. Council of Scientific and Industrial Research India Website Archived 2015-09-27 at the Wayback Machine.
  2. Zebrafish Genome Webpage Archived 19 July 2018 at the Wayback Machine 'Institute of Genomics and Integrative Biology' (IGIB)
  3. Decoding the Genome Mystery Indian Express, 5 July 2009.
  4. Indian Scientists decode human genome Indian Express, 10 December 2009
  6. Compilation of news articles and Press releases on Indian Genome, 10 December 2009
  7. "Sri Lankan genome". Archived from the original on 18 February 2013. Retrieved 17 January 2013.
  8. Dissanayake VH, Samarakoon PS, Scaria V, Patowary A, Sivasubbu S, Gokhale RS, et al. (2012). "The Sri Lankan Personal Genome Project: an overview". Sri Lanka Journal of Biomedical Informatics. 1 (2): 4–8.CS1 maint: ref=harv (link) Archived 5 April 2013 at the Wayback Machine
  9. "Wedding Day Ancilleries".
  10. "OpenPGx Consortium". Archived from the original on 18 December 2017. Retrieved 7 November 2018.
  11. Bhoyar, Rahul C.; Jain, Abhinav; Sehgal, Paras; Divakar, Mohit Kumar; Sharma, Disha; Imran, Mohamed; Jolly, Bani; Ranjan, Gyan; Rophina, Mercy; Sharma, Sumit; Siwach, Sanjay (10 August 2020). "High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing". bioRxiv: 2020.08.10.242677. doi:10.1101/2020.08.10.242677.
  12. Genomics for Understanding Rare Diseases India Alliance Network (GUaRDIAN)
  13. Sivasubbu S, Scaria V, et al. (GUaRDIAN Consortium) (September 2019). "Genomics of rare genetic diseases-experiences from India". Human Genomics. 14 (1): 52. doi:10.1186/s40246-019-0215-5. PMC 6760067. PMID 31554517.
  14. Scaria V, Sivasubbu S (2015). Exome Sequence Analysis and Interpretation - Handbook for Clinicians (First ed.). The Readers Paradise. ISBN 978-93-82110-58-3.
  15. Gupta A, Sharma YK, Vellarikkal SK, Jayarajan R, Dixit V, Verma A, et al. (April 2016). "Whole-exome sequencing solves diagnostic dilemma in a rare case of sporadic acrokeratosis verruciformis". Journal of the European Academy of Dermatology and Venereology. 30 (4): 695–7. doi:10.1111/jdv.12983. PMID 25622760.CS1 maint: ref=harv (link)
  16. Gupta A, Sharma Y, Deo K, Vellarikkal S, Jayarajan R, Dixit V, et al. (2015). "Case Report: Whole exome sequencing helps in accurate molecular diagnosis in siblings with a rare co-occurrence of paternally inherited 22q12 duplication and autosomal recessive non-syndromic ichthyosis". F1000Research. 4: 446. doi:10.12688/f1000research.6779.1. PMC 4648218. PMID 26594337.CS1 maint: ref=harv (link)
  17. Vellarikkal SK, Patowary A, Singh M, Kumari R, Faruq M, Master DC, et al. (2014). "Exome sequencing reveals a novel mutation, p.L325H, in the KRT5 gene associated with autosomal dominant Epidermolysis Bullosa Simplex Koebner type in a large family from western India". Human Genome Variation. 1 (1): 14007. doi:10.1038/hgv.2014.7. PMC 4785511. PMID 27081501.CS1 maint: ref=harv (link)
  18. Patient Referral Page Genomics for Understanding Rare Diseases India Alliance Network (GUaRDIAN)
  19. "Genomics for Public Health". sites.google.com. Retrieved 3 September 2019.
  20. HGM-2008 website Archived 2 October 2016 at the Wayback Machine.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.